DAPSA与超声在银屑病关节炎疾病活动度评估中呈现不同视角:生物制剂起始治疗患者12个月纵向观察研究
本研究纳入47例起始生物制剂治疗的银屑病关节炎患者,在基线及3、6、9、12个月评估DAPSA、临床指标与超声(GS和PD)。结果显示DAPSA与PD无纵向关联,而66SJC、ESR、DAS28、EGA和CRP与PD关联;DAPSA与PD缓解无显著关联,提示二者评估PsA活动度的不同方面。
要点
- DAPSA与超声PD无纵向关联,提示二者评估PsA活动度的不同维度。
- 66SJC、ESR、DAS28、EGA和CRP与PD纵向关联,而68TJC、疼痛及PROMs无关联。
- 6-12个月DAPSA缓解率29%-33%,PD缓解率59%-70%,二者关联不显著(p=0.33)。
核心结论
- DAPSA与超声炎症表现无关联,提示DAPSA和超声可能评估PsA活动度的不同方面。
研究设计与样本
- 纵向观察性研究,纳入47例起始生物制剂治疗的银屑病关节炎患者,在基线及3、6、9、12个月进行评估。
- 评估包括68TJC/66SJC、EGA、PROMs、CRP、ESR及超声GS和PD(48个关节、10条屈肌腱、14个附着点、4个滑囊)。
- 采用广义估计方程进行线性和逻辑回归分析纵向关联。
主要发现
- DAPSA与PD无纵向关联。
- 66SJC、ESR、DAS28、EGA和CRP与PD纵向关联(p<0.001-0.03)。
- DAPSA中疼痛相关成分(68TJC和疼痛)以及PROMs与PD无关联。
- 6-12个月时,DAPSA缓解率为29%-33%,PD缓解率为59%-70%。
- DAPSA与PD缓解的关联不显著(p=0.33)。
关键数值与推荐
- DAPSA缓解率在6-12个月为29%-33%,PD缓解率(PD总和评分0=缓解)为59%-70%。
- DAPSA与PD缓解关联的p=0.33。
临床怎么用
- 临床评估PsA活动度时,DAPSA与超声可能提供互补信息,不应互相替代。
- 对起始生物制剂治疗的患者,可考虑结合超声PD评估以更全面判断炎症活动。
局限性
- 样本量较小(47例),可能影响结果的普遍性。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Disease Activity index for PSoriatic Arthritis (DAPSA) (sum score 68/66 tender/swollen joint counts (68TJC/66SJC), patient's global assessment, pain and C-reactive protein (CRP)) is recommended for clinical assessment of disease activity in patients with psoriatic arthritis (PsA). Ultrasound (US) (grey scale (GS) and power Doppler (PD)) detects inflammation in joints and extra-articular structures. The present objectives were to explore the longitudinal relationships between DAPSA, clinical assessment as well as patient-reported outcome measures (PROMs) with US in patients with PsA initiating biological DMARDs and the associations between DAPSA and US remission. METHODS: 47 patients with PsA were examined at baseline and after 3, 6, 9 and 12 months. Assessments included 68TJC/66SJC, examiner's global assessment (EGA), PROMs, CRP, erythrocyte sedimentation rate (ESR) and US GS and PD (48 joints, 10 flexor tendons, 14 entheses, 4 bursae). Clinical composite scores and PD sum scores (0=remission) were calculated. Longitudinal associations were explored by generalised estimating equations with linear and logistic regression. RESULTS: DAPSA was not longitudinally associated to PD. 66SJC, ESR, 28-joint Disease Activity Score, EGA and CRP were longitudinally associated with PD (p<0.001-0.03), whereas the pain-related components of DAPSA (68TJC and pain) as well as PROMs were not associated. At 6-12 months, remission was achieved in 29%-33 % of the patients for DAPSA and 59%-70 % for PD. The association between DAPSA and PD remission was not significant (p=0.33). CONCLUSIONS: DAPSA was not associated with US inflammatory findings which indicates that DAPSA and US may assess different aspects of PsA activity.
引用
- Pukšić S, Bolton-King P, Sexton J, et al. DAPSA and ultrasound show different perspectives of psoriatic arthritis disease activity: results from a 12-month longitudinal observational study in patients starting treatment with biological disease-modifying antirheumatic drugs. RMD Open. 2018. PMID: 30487999. doi:10.1136/rmdopen-2018-000765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。